Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tactile Systems Technology Inc. (TCMD:NASDAQ), powered by AI.
Tactile Systems Technology Inc. is currently trading at $26.43. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Tactile Systems Technology Inc. on Alpha Lenz.
Tactile Systems Technology Inc.'s P/E ratio is 31.7.
“Tactile Systems Technology Inc. trades at a P/E of 31.7 (premium valuation) with solid ROE of 8.8%. 3Y revenue CAGR of 10.1% highlights clear growth momentum.”
Ask for details →Tactile Systems Technology Inc. is a medical device company specializing in the development and marketing of therapeutic products for patients with chronic diseases. Its primary function is to produce and distribute advanced pneumatic compression devices aimed at treating chronic swelling conditions such as lymphedema and chronic venous insufficiency. These devices are designed to alleviate symptoms, improve patient mobility, and ultimately enhance quality of life. The company serves a range of healthcare sectors, including home healthcare providers, hospitals, and clinics, ensuring its products reach a wide array of patients who require this specialized form of care. Tactile Systems Technology Inc. plays a significant role in the healthcare market by focusing on non-invasive treatment options that can lead to more effective patient management solutions. Based in the United States, the company is recognized for its commitment to innovation and its contribution to the enhancement of healthcare delivery in chronic care management sectors.
“Tactile Systems Technology Inc. trades at a P/E of 31.7 (premium valuation) with solid ROE of 8.8%. 3Y revenue CAGR of 10.1% highlights clear growth momentum.”
Ask for details →Tactile Systems Technology Inc. (ticker: TCMD) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 1,037 employees. Market cap is $605M.
The current price is $26.43 with a P/E ratio of 31.67x and P/B of 2.76x.
ROE is 8.77% and operating margin is 8.89%. Annual revenue is $330M.